Clinical Biochemistry and Urinalysis: Principles, Methods, and Diagnostic Interpretation in Veterinary Medicine

Introduction

Clinical biochemistry and urinalysis are cornerstone diagnostic modalities in veterinary medicine, providing objective data on organ function, metabolic status, and systemic disease processes. Serum or plasma biochemistry panels quantify enzymes, substrates, electrolytes, and waste products that reflect the functional integrity of the liver, kidneys, pancreas, muscle, and endocrine systems [1]. Urinalysis complements these measurements by assessing renal concentrating ability, detecting urinary tract inflammation or infection, and identifying metabolic derangements such as glucosuria or ketonuria [2]. The integration of biochemical and urinalysis findings with physical examination and other diagnostic tests allows the clinician to formulate differential diagnoses, monitor disease progression, and evaluate therapeutic responses [1, 2].

This article reviews the biophysical and chemical principles underlying common veterinary biochemistry and urinalysis assays, the interpretation of organ-specific biomarkers, and the systematic approach to urine examination. Emphasis is placed on preanalytical variables, analytical methodology, and species-specific reference intervals.

Clinical Biochemistry: Analytical Principles and Organ-Specific Biomarkers

Preanalytical Considerations

Sample quality profoundly affects biochemical results. Hemolysis, lipemia, and icterus interfere with spectrophotometric assays by altering light absorbance at specific wavelengths [1]. Serum is preferred for most analytes, although heparinized plasma is acceptable for many tests and allows faster separation [2]. Prolonged contact of serum with cells leads to leakage of intracellular enzymes (e.g., potassium, lactate dehydrogenase) and consumption of glucose [1]. Storage at 4 degrees Celsius for more than 24 hours may degrade bilirubin and increase ammonia concentrations [2].

Automated Chemistry Analyzers

Modern veterinary laboratories employ automated wet-chemistry or dry-slide analyzers that use spectrophotometry, ion-selective electrodes, and enzymatic methods [1]. In spectrophotometry, a chromogenic reaction produces a color proportional to the analyte concentration, measured at a specific wavelength [2]. Ion-selective electrodes directly measure electrolyte activity in undiluted samples [1]. Dry-slide technology uses multilayered films that separate plasma components and initiate reactions; reflectance photometry quantifies the color change [2].

Hepatic Biomarkers

The liver performs synthetic, metabolic, and excretory functions. Biochemical assessment includes measurement of hepatocellular leakage enzymes, cholestatic markers, and functional tests [1].

Alanine aminotransferase (ALT) is a cytosolic enzyme abundant in canine and feline hepatocytes; leakage into serum indicates hepatocellular injury [1, 2]. Aspartate aminotransferase (AST) is present in liver, muscle, and red blood cells; its specificity for liver disease is lower than ALT [1]. Alkaline phosphatase (ALP) is membrane-bound and increases with cholestasis, corticosteroid induction, or bone growth [2]. In dogs, glucocorticoid-induced ALP is a specific isoenzyme [1]. Gamma-glutamyltransferase (GGT) is a more specific cholestatic marker in horses and ruminants [2].

Functional hepatic tests include bilirubin (total and direct), bile acids (fasting and postprandial), and ammonia [1]. Hyperbilirubinemia results from prehepatic (hemolysis), hepatic, or posthepatic (obstruction) causes [2]. Bile acid measurement is sensitive for portosystemic shunts and hepatic insufficiency [1].

Renal Biomarkers

The kidney filters blood, reabsorbs solutes, and excretes waste. Serum biomarkers of renal function include creatinine, blood urea nitrogen (BUN), and symmetric dimethylarginine (SDMA) [1, 2].

Creatinine is a byproduct of muscle creatine metabolism; it is freely filtered and not reabsorbed, making it a reliable indicator of glomerular filtration rate (GFR) [1]. However, creatinine is insensitive for early renal disease because GFR must decline by approximately 75% before serum creatinine exceeds the reference interval [2]. BUN is influenced by protein intake, hepatic function, and dehydration, reducing its specificity for renal disease [1].

SDMA is a methylated arginine derivative that is also freely filtered; it increases earlier than creatinine in chronic kidney disease and is not affected by muscle mass [2]. Phosphorus and potassium may be elevated in advanced renal failure due to reduced excretion [1].

Pancreatic Biomarkers

Pancreatic disease is assessed by measuring digestive enzymes and specific lipases. Amylase and lipase are produced by the exocrine pancreas but also by other tissues; their specificity for pancreatitis is limited [1]. Pancreatic lipase immunoreactivity (PLI) is species-specific and highly sensitive for pancreatitis in dogs and cats [2]. Trypsin-like immunoreactivity (TLI) measures pancreatic trypsinogen and is used to diagnose exocrine pancreatic insufficiency (low TLI) or pancreatitis (elevated TLI) [1].

Muscle and Cardiac Biomarkers

Creatine kinase (CK) is a cytosolic enzyme abundant in skeletal and cardiac muscle; it rises rapidly after muscle injury and declines within 24–48 hours [1]. AST also increases with muscle damage but is less specific [2]. Cardiac troponin I (cTnI) is a regulatory protein unique to cardiac myocytes; its elevation indicates myocardial injury and is used in the diagnosis of myocarditis, cardiomyopathy, and cardiac contusions [1, 2].

Electrolytes and Acid-Base Balance

Sodium, potassium, chloride, and bicarbonate are measured by ion-selective electrodes or enzymatic methods [1]. Calcium exists in ionized (active), protein-bound, and complexed forms; total calcium measurement must be corrected for albumin concentration [2]. Phosphorus and magnesium are also routinely measured [1].

Acid-base status is evaluated by blood gas analysis, which measures pH, partial pressure of carbon dioxide (pCO2), and bicarbonate (HCO3-) [2]. The anion gap (Na+ + K+ – Cl- – HCO3-) helps differentiate metabolic acidosis causes [1].

Reference Intervals

Reference intervals are species-specific and ideally laboratory-specific. They are established from healthy populations using nonparametric methods [1]. Table 1 provides example reference intervals for common analytes in dogs and cats.

Table 1. Example Serum Biochemistry Reference Intervals for Dogs and Cats

Note: Values are illustrative; each laboratory should validate its own intervals [1, 2].

Urinalysis: Physical, Chemical, and Microscopic Examination

Urinalysis provides information on renal function, urinary tract integrity, and systemic metabolism. A complete urinalysis includes physical assessment, chemical reagent strip testing, and microscopic sediment examination [2].

Physical Properties

Color ranges from pale yellow to amber due to urochrome concentration. Abnormal colors include red (hematuria, hemoglobinuria), brown (myoglobinuria, bilirubinuria), and orange (concentrated bilirubin) [1]. Turbidity may result from cells, crystals, bacteria, or mucus [2].

Specific gravity (USG) measures urine concentration and is determined by refractometry. USG reflects renal concentrating ability; isosthenuria (USG 1.008–1.012) indicates loss of concentrating capacity, as seen in chronic kidney disease [1]. Volume is not routinely measured in voided samples but is important in metabolic cage collections [2].

Chemical Reagent Strip Analysis

Multiparameter reagent strips detect pH, protein, glucose, ketones, bilirubin, urobilinogen, blood, nitrite, and leukocyte esterase [1]. Interpretation must account for species differences and interferences.

pH varies with diet and acid-base status. Carnivores typically have acidic urine (pH 5.5–7.0); herbivores produce alkaline urine [2]. Protein is detected by a colorimetric dye-binding method; trace to 1+ protein may be normal in concentrated urine, but persistent proteinuria warrants quantification by urine protein-to-creatinine ratio (UPC) [1].

Glucose appears in urine when blood glucose exceeds the renal threshold (approximately 180 mg/dL in dogs, 280 mg/dL in cats) [2]. Ketones (acetoacetate) indicate diabetic ketoacidosis or starvation [1]. Bilirubin is normally absent in canine urine; trace amounts may be present in concentrated samples, but higher levels suggest cholestasis [2]. Blood (hemoglobin or myoglobin) is detected by pseudoperoxidase activity; intact red cells lyse on the strip, so a positive blood pad without visible sediment erythrocytes suggests hemoglobinuria or myoglobinuria [1].

Nitrite and leukocyte esterase are less reliable in veterinary samples; bacterial nitrate reductase is not present in all uropathogens, and feline leukocytes may not produce sufficient esterase [2].

Microscopic Sediment Examination

Sediment is prepared by centrifuging 5–10 mL of urine at 1500–2000 rpm for 5 minutes, decanting the supernatant, and resuspending the pellet in 0.5 mL of residual urine [1]. A drop is placed on a slide with a coverslip and examined under low (10x) and high (40x) power.

Cells: Red blood cells (>5 per high-power field (hpf) indicate hematuria), white blood cells (>5/hpf suggest inflammation or infection), and epithelial cells (transitional, renal tubular, or squamous) [2]. Casts: Hyaline, granular, cellular (red cell, white cell, epithelial), and waxy casts indicate tubular injury or stasis [1]. Crystals: Struvite (magnesium ammonium phosphate), calcium oxalate, urate, cystine, and others; their clinical significance depends on species, urine pH, and quantity [2]. Bacteria: Rods or cocci; presence with pyuria suggests urinary tract infection [1]. Lipid droplets are common in feline urine and usually insignificant [2].

Urine Protein-to-Creatinine Ratio (UPC)

UPC quantifies proteinuria and is indicated when dipstick protein is ≥2+ or when persistent proteinuria is suspected [1]. A UPC <0.5 is normal in dogs and cats; 0.5–1.0 is borderline; >1.0 indicates significant proteinuria [2]. UPC is used to stage chronic kidney disease and monitor glomerular disease [1].

Diagnostic Interpretation and Clinical Integration

Biochemical and urinalysis results must be interpreted in the context of the patient’s signalment, history, physical findings, and other diagnostics. For example, azotemia (elevated BUN and creatinine) with isosthenuria indicates primary renal disease, whereas prerenal azotemia shows concentrated urine [1]. Hyperbilirubinemia with elevated ALP and GGT suggests cholestasis, while elevated ALT and AST indicate hepatocellular injury [2].

A systematic approach to interpreting a biochemistry panel involves evaluating each analyte in relation to others. For instance, hypokalemia with metabolic alkalosis in a vomiting dog suggests gastric outflow obstruction [1]. Hypercalcemia with low phosphorus may indicate hyperparathyroidism or malignancy [2].

Workflow for Clinical Biochemistry and Urinalysis

The following Mermaid diagram outlines a diagnostic workflow integrating biochemistry and urinalysis.

flowchart TD
    A[Patient with clinical signs] --> B[Collect blood and urine]
    B --> C{Biochemistry panel}
    C --> D[Evaluate hepatic markers]
    C --> E[Evaluate renal markers]
    C --> F[Evaluate pancreatic/muscle markers]
    C --> G[Electrolytes and acid-base]
    B --> H[Urinalysis]
    H --> I["Physical: color, USG"]
    H --> J["Chemical: dipstick"]
    H --> K[Microscopic sediment]
    D --> L["Interpret pattern: hepatocellular vs. cholestatic"]
    E --> M["Interpret azotemia: prerenal, renal, postrenal"]
    F --> N[Interpret enzyme elevations]
    G --> O[Assess electrolyte imbalances]
    I --> P[Assess concentrating ability]
    J --> Q[Detect glucosuria, proteinuria, etc.]
    K --> R[Identify cells, casts, crystals, bacteria]
    L --> S[Integrated diagnosis]
    M --> S
    N --> S
    O --> S
    P --> S
    Q --> S
    R --> S
    S --> T[Formulate differential diagnoses and plan]

Conclusion

Clinical biochemistry and urinalysis are essential, complementary tools in veterinary diagnostics. Understanding the biophysical principles of each assay, the preanalytical variables that affect results, and the species-specific interpretation of biomarkers allows the clinician to accurately assess organ function and metabolic status. Integration of these data with other clinical findings supports evidence-based decision-making in patient management.

References

[1] Kaneko JJ, Harvey JW, Bruss ML. Clinical Biochemistry of Domestic Animals. 6th ed. Academic Press; 2008.

[2] Stockham SL, Scott MA. Fundamentals of Veterinary Clinical Pathology. 2nd ed. Blackwell Publishing; 2008. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.